Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ: ANIP) will be reporting earnings this Friday before market open. Here’s what you need to know.
ANI Pharmaceuticals beat analysts’ revenue expectations last quarter, reporting revenues of $247.1 million, up 29.6% year on year. It was a stunning quarter for the company, with an impressive beat of analysts’ revenue estimates and a solid beat of analysts’ full-year EPS guidance estimates.
Is ANI Pharmaceuticals a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting ANI Pharmaceuticals’s revenue to grow 5.6% year on year, slowing from the 43.4% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. ANI Pharmaceuticals has a history of exceeding Wall Street’s expectations.
Looking at ANI Pharmaceuticals’s peers in the pharmaceuticals segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Phibro Animal Health delivered year-on-year revenue growth of 10.3%, beating analysts’ expectations by 8%, and Eli Lilly reported revenues up 55.5%, topping estimates by 13.7%. Eli Lilly traded up 13.2% following the results.
Read our full analysis of Phibro Animal Health’s results here and Eli Lilly’s results here.
There has been positive sentiment among investors in the pharmaceuticals segment, with share prices up 6.8% on average over the last month. ANI Pharmaceuticals is up 5.8% during the same time and is heading into earnings with an average analyst price target of $110.63 (compared to the current share price of $84.04).
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
